Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

NCT07476170 · clinicaltrials.gov ↗

RECRUITING

Status

14000

Enrollment

INDUSTRY

Sponsor class

Conditions

HR+/HER2- Advanced or Metastatic Breast Cancer

Sponsor

Novartis Pharmaceuticals